Hearing loss in patients with Laron syndrome (primary growth hormone insensitivity) is reversed by early IGF-I replacement therapy

被引：0
|
作者：
Attias, Joseph [1 ,2 ]
Negeris, Benny [2 ,3 ]
Zarhi, Omer [1 ,2 ]
Laron, Zvi [1 ,2 ]
机构：
[1] Schneider Childrens Med Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Petah Tiqwa, Israel
[3] Rabin Med Ctr, Petah Tiqwa, Israel
来源：
HORMONE RESEARCH | 2008年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [31] Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron syndrome)
    Laron, Z
    Klinger, B
    Silbergeld, A
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1999, 12 (02): : 145 - 152
  • [32] TISSUES OF THE LARON DWARF ARE SENSITIVE TO INSULIN-LIKE GROWTH-FACTOR I (IGF-I) BUT NOT TO GROWTH-HORMONE (GH)
    GEFFNER, ME
    GOLDE, DW
    LIPPE, BM
    KAPLAN, SA
    BERSCH, N
    [J]. CLINICAL RESEARCH, 1987, 35 (01): : A222 - A222
  • [33] Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome
    Klinger, B
    Anin, S
    Silbergeld, A
    Eshet, R
    Laron, Z
    [J]. CLINICAL ENDOCRINOLOGY, 1998, 48 (01) : 81 - 87
  • [34] Increased neutrophil insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced functional capacity in patients with untreated Laron syndrome
    Bjerknes, R
    Vesterhus, P
    Aarskog, D
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (01) : 92 - 95
  • [35] Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein
    Kanety, H
    Silbergeld, A
    Klinger, B
    Karasik, A
    Baxter, RC
    Laron, Z
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 137 (06) : 626 - 630
  • [36] Growth and Body Composition in Children with Growth Hormone Insensitivity Treated with Recombinant Insulin-like Growth Factor I (IGF-I) † 407
    Steven D Chernausek
    John C Bucuvalas
    Jo Ann Horn
    Paul M Martha
    Joyce Kuntze
    [J]. Pediatric Research, 1998, 43 (Suppl 4) : 72 - 72
  • [37] Extensive personal experience - Laron syndrome (primary growth hormone resistance or insensitivity): The personal experience 1958-2003
    Laron, Z
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03): : 1031 - 1044
  • [38] EFFECT OF GONADECTOMY ON GROWTH-HORMONE, IGF-I AND SEX STEROIDS IN CHILDREN WITH COMPLETE AND INCOMPLETE ANDROGEN INSENSITIVITY
    CICOGNANI, A
    CACCIARI, E
    TACCONI, M
    PASCUCCI, MG
    TONIOLI, S
    PIRAZZOLI, P
    BALSAMO, A
    [J]. ACTA ENDOCRINOLOGICA, 1989, 121 (06): : 777 - 783
  • [39] IGF-I treatment of patients with Laron syndrome suppresses serum thrombopoietin levels but does not affect serum erythropoietin
    Shevah, Orit
    Yacobovich, Joanne
    Zoldan, Meira
    Tamary, Hannah
    Laron, Zvi
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (01) : 64 - 64
  • [40] Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion
    Camacho-Hübner, C
    Woods, KA
    Miraki-Moud, F
    Hindmarsh, PC
    Clark, AJ
    Hansson, Y
    Johnston, A
    Baxter, RC
    Savage, MO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05): : 1611 - 1616
12345